Conventional drinking water treatment and direct biofiltration for the removal of pharmaceuticals and artificial sweeteners: A pilot-scale approach

Abstract

The presence of endocrine disrupting compounds (EDCs), pharmaceutically active compounds (PhACs) and artificial sweeteners are of concern to water providers because they may be incompletely removed by wastewater treatment processes and they pose an unknown risk to consumers due to long-term consumption of low concentrations of these compounds. This study utilized pilot-scale conventional and biological drinking water treatment processes to assess the removal of nine PhACs and EDCs, and two artificial sweeteners. Conventional treatment (coagulation, flocculation, settling, non-biological dual-media filtration) was compared to biofilters with or without the addition of in-line coagulant (0.2–0.8mgAl3+/L; alum or PACl). A combination of biofiltration, with or without in-line alum, and conventional filtration was able to reduce 7 of the 9 PhACs and EDCs by more than 50% from river water while artificial sweeteners were inconsistently removed by conventional treatment or biofiltration. Increasing doses of PACl from 0 to 0.8mg/L resulted in average removals of PhACs, EDCs increasing from 39 to 70% and artificial sweeteners removal increasing from ~15% to ~35% in lake water. These results suggest that a combination of biological, chemical and physical treatment can be applied to effectively reduce the concentration of EDCs, PhACs, and artificial sweeteners.